Bowling Portfolio Management LLC Upped Biogen INC (BIIB) Position by $3.38 Million

Biogen Inc. (NASDAQ:BIIB) LogoInvestors sentiment decreased to 0.91 in 2018 Q4. Its down 0.10, from 1.01 in 2018Q3. It fall, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. Altrinsic Advsrs Limited Liability Company reported 1.35% stake. Boltwood Cap reported 1,987 shares. Rathbone Brothers Plc stated it has 0.04% in Biogen Inc. (NASDAQ:BIIB). Royal Comml Bank Of Canada invested in 397,941 shares. The Pennsylvania-based Stoneridge Inv Prns Lc has invested 4.43% in Biogen Inc. (NASDAQ:BIIB). Acadian Asset Mgmt Ltd has invested 0.02% in Biogen Inc. (NASDAQ:BIIB). Gam Holding Ag holds 0.21% or 13,477 shares. Keybank Association Oh accumulated 15,943 shares. Bankshares holds 0.11% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 29,982 shares. First Personal Serv accumulated 0.01% or 129 shares. Bp Public Ltd accumulated 23,000 shares. Victory Inc owns 52,060 shares. United Service Automobile Association holds 236,651 shares. Atria Invests Ltd Liability Co invested 0.09% in Biogen Inc. (NASDAQ:BIIB). Berkshire Asset Management Ltd Liability Company Pa owns 2,002 shares or 0.06% of their US portfolio.

Since January 30, 2019, it had 2 insider purchases, and 0 sales for $47.78 million activity.

Bowling Portfolio Management Llc increased its stake in Biogen Inc (BIIB) by 281.8% based on its latest 2018Q4 regulatory filing with the SEC. Bowling Portfolio Management Llc bought 11,258 shares as the company’s stock declined 1.50% while stock markets rallied. The institutional investor held 15,253 shares of the biological products (no diagnostic substances) company at the end of 2018Q4, valued at $4.59M, up from 3,995 at the end of the previous reported quarter. Bowling Portfolio Management Llc who had been investing in Biogen Inc for a number of months, seems to be bullish on the $44.84B market cap company. The stock increased 0.99% or $2.26 during the last trading session, reaching $231.28. About 1.02 million shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since May 8, 2018 and is uptrending. It has outperformed by 11.54% the S&P500.

Bowling Portfolio Management Llc, which manages about $492.89 million and $565.25M US Long portfolio, decreased its stake in Lockheed Martin Corp (NYSE:LMT) by 13,393 shares to 12,453 shares, valued at $3.26M in 2018Q4, according to the filing. It also reduced its holding in Amgen Inc. (NASDAQ:AMGN) by 23,370 shares in the quarter, leaving it with 11,305 shares, and cut its stake in Foot Locker Inc (NYSE:FL).

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Nasdaq.com which released: “Biogen Earnings: BIIB Stock Slips Despite Q1 Beat – Nasdaq” on April 24, 2019, also Nasdaq.com with their article: “This ETF Holds Stocks Insiders Want to Own – Nasdaq” published on May 07, 2019, Nasdaq.com published: “Monday 5/6 Insider Buying Report: BIIB, UNH – Nasdaq” on May 06, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Nasdaq.com and their article: “Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales – Nasdaq” published on April 24, 2019 as well as Seekingalpha.com‘s news article titled: “Biogen Q1 2019 Earnings Preview – Seeking Alpha” with publication date: April 23, 2019.

Biogen Inc. (NASDAQ:BIIB) Ratings Coverage

Among 18 analysts covering Biogen (NASDAQ:BIIB), 8 have Buy rating, 0 Sell and 10 Hold. Therefore 44% are positive. Biogen had 37 analyst reports since December 19, 2018 according to SRatingsIntel. The stock of Biogen Inc. (NASDAQ:BIIB) has “Neutral” rating given on Friday, February 22 by Guggenheim. The stock has “Hold” rating by RBC Capital Markets on Monday, March 25. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Thursday, March 21 by Cowen & Co. As per Thursday, March 21, the company rating was maintained by Piper Jaffray. The rating was maintained by Cowen & Co on Monday, March 4 with “Buy”. The rating was maintained by BMO Capital Markets on Friday, March 22 with “Hold”. The firm earned “Hold” rating on Thursday, March 21 by Canaccord Genuity. Bank of America downgraded the shares of BIIB in report on Thursday, March 21 to “Hold” rating. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Neutral” rating by Mizuho on Friday, March 22. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Buy” rating by H.C. Wainwright on Tuesday, February 19.

Biogen Inc. (NASDAQ:BIIB) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.